Business Context and Reporting Period
This Form 8-K was filed by PolyOne Corporation (now Avient Corp) on March 8, 2017. The report discloses a corporate governance change involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The Board of Directors increased its size from ten to eleven members. Kim Ann Mink was elected as a director, effective immediately, with an initial term ending at the 2017 Annual Meeting of Shareholders. Dr. Mink was also appointed to the Environmental, Health and Safety Committee.
Management Commentary and Compensation
Dr. Mink, currently the Chairman, President, and CEO of Innophos Holdings, Inc., brings experience from Dow Chemical Company and ANGUS Chemical Co. As a non-employee director, she will receive compensation consistent with other directors. Effective October 1, 2016, the annual retainer was increased to $210,000, consisting of $95,000 in cash and $115,000 in fully vested common shares. An Indemnification Agreement was also entered into with Dr. Mink.
Investor Verification Checklist
- Confirm the effective date of Dr. Mink's directorship and committee assignment.
- Verify the total annual compensation package ($210,000) and the split between cash and equity.
- Review the terms of the Indemnification Agreement referenced in the filing.
- Check the company's definitive proxy statement (Schedule 14A) filed on April 1, 2016, for historical director compensation details.